0001104659-24-011598.txt : 20240207
0001104659-24-011598.hdr.sgml : 20240207
20240207160035
ACCESSION NUMBER: 0001104659-24-011598
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240206
FILED AS OF DATE: 20240207
DATE AS OF CHANGE: 20240207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gagnon Robert E.
CENTRAL INDEX KEY: 0001504983
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35403
FILM NUMBER: 24604207
MAIL ADDRESS:
STREET 1: C/O BIOGEN IDEC INC.
STREET 2: 133 BOSTON POST ROAD
CITY: WESTON
STATE: MA
ZIP: 02493
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verastem, Inc.
CENTRAL INDEX KEY: 0001526119
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 273269467
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 500
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: (781) 292-4200
MAIL ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 500
CITY: NEEDHAM
STATE: MA
ZIP: 02494
4
1
tm245463-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-06
0
0001526119
Verastem, Inc.
VSTM
0001504983
Gagnon Robert E.
C/O VERASTEM, INC., 117 KENDRICK ST.,
SUITE 500
NEEDHAM
MA
02494
1
0
0
0
1
Common Stock
2024-02-06
4
S
0
9204
13.70
D
27804
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $13.50 through $13.97, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein.
/s/ Daniel Calkins, Attorney in Fact
2024-02-07